Omalizumab Seems Safe, Effective for Real-World Chronic Idiopathic Urticaria Omalizumab Seems Safe, Effective for Real-World Chronic Idiopathic Urticaria

In real-world patients with chronic idiopathic urticaria (CIU), omalizumab meets or exceeds the safety and efficacy results seen in clinical trials, researchers say.Reuters Health Information (Source: Medscape Allergy Headlines)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2r98gSw